Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GemVax's highly promising Phase II Alzheimer's disease clinical trial results targeting telomerase published in prestigious Alzheimer's Research & Therapy' journal 2021-03-30 19:21
1